Related by context. All words. (Click for frequent words.) 75 myelodysplastic syndromes 75 leukemia AML 70 cell lymphoma CTCL 70 B CLL 70 myelodysplastic syndromes MDS 70 grade cervical intraepithelial 70 recurrent NSCLC 70 pancreatic NET 70 acute myelogenous leukemia AML 69 lupus nephritis 69 leukemia ALL 68 homozygous familial hypercholesterolemia 68 acute leukemias 68 grade gliomas 68 myelofibrosis polycythemia vera 68 myeloproliferative neoplasms 68 non metastatic osteosarcoma 68 acute myeloid leukemia AML 68 atypical hemolytic uremic syndrome 68 mycosis fungoides 68 grade glioma 68 metastatic malignant 68 Chronic lymphocytic leukemia 68 relapsed refractory multiple myeloma 68 soft tissue sarcomas 68 myelodysplastic syndrome 67 gastrointestinal stromal tumor 67 Myelodysplastic Syndrome 67 idiopathic thrombocytopenic purpura ITP 67 systemic lupus erythematosus 67 smoldering myeloma 67 hematologic disorders 67 Hodgkin lymphoma NHL 67 metastatic renal cell carcinoma 67 Cloretazine 67 Follicular Lymphoma 67 cutaneous T 67 HBeAg negative 67 metastatic bladder 66 gastrointestinal stromal tumors 66 ara C 66 chronic myelogenous leukemia CML 66 leukemia CLL 66 metastatic malignant melanoma 66 relapsing remitting 66 Myelofibrosis 66 SJIA 66 chronic lymphocytic leukemia CLL 66 essential thrombocythemia 66 myelodysplasia 66 lymphoma CTCL 66 Acute Myeloid Leukemia AML 66 hypercalcemia 66 refractory chronic lymphocytic 66 Amrubicin 66 malignant pleural mesothelioma 66 stage IIIB 66 MALT lymphoma 66 Acute Myelogenous Leukemia AML 66 opioid induced constipation OIC 66 AA amyloidosis 65 IV NSCLC 65 basal cell carcinoma BCC 65 recurrent glioblastoma multiforme 65 Hodgkin lymphoma HL 65 nonsmall cell lung cancer 65 macroalbuminuria 65 indolent NHL 65 pancreatic carcinoma 65 Hepatocellular Carcinoma HCC 65 familial hypercholesterolemia 65 Cutaneous T 65 cutaneous T cell 65 secondary hyperparathyroidism 65 leukemia APL 65 acute GvHD 65 TTR amyloidosis 65 smoldering multiple myeloma 65 hematological malignancy 65 Gleevec resistant 65 myelofibrosis 65 tumors GIST 65 acute myeloid 65 atypical Hemolytic Uremic Syndrome 65 relapsed refractory 65 chronic eosinophilic leukemia 65 non alcoholic steatohepatitis 65 Metastatic breast cancer 65 neuroendocrine cancers 65 Carcinoma 65 Epratuzumab 65 haematologic 65 myeloid leukemia 65 Chronic lymphocytic leukemia CLL 65 myelodysplastic myeloproliferative diseases 65 hypereosinophilic syndrome 64 mRCC 64 hepatocellular carcinomas 64 invasive candidiasis 64 Chronic Myelogenous Leukemia CML 64 Sezary syndrome 64 Acute Myeloid Leukemia 64 immune thrombocytopenic purpura 64 Waldenstrom macroglobulinemia 64 Alemtuzumab 64 receptor tyrosine kinase inhibitor 64 lupus erythematosus 64 thymoma 64 cell chronic lymphocytic 64 aHUS 64 unresectable 64 gefitinib Iressa 64 lymphocytic leukemia 64 colorectal carcinoma 64 relapsed MM 64 familial amyloidotic polyneuropathy FAP 64 cytopenias 64 Omacetaxine 64 Uricase PEG 64 complement inhibitor eculizumab 64 Acute Myelogenous Leukemia 64 differentiated thyroid 64 renal cell carcinoma 64 ADPKD 64 grade cervical dysplasia 64 erlotinib Tarceva ® 64 follicular lymphoma FL 64 myeloproliferative diseases 64 recurrent glioblastoma 64 refractory acute myeloid 64 Ph + ALL 64 TNF antagonist 64 thalidomide Thalomid 64 acute coronary syndromes ACS 64 Fludarabine 64 posterior uveitis 64 pheochromocytoma 64 HER2 positive metastatic breast 63 Glioblastoma Multiforme 63 Zolinza 63 dasatinib Sprycel ® 63 Toxicities 63 Myelodysplastic Syndrome MDS 63 purpura ITP 63 hypercholesterolemic patients 63 CYT# potent vascular disrupting 63 phase IIb clinical 63 metastatic renal cell 63 Follicular lymphoma 63 Philadelphia Chromosome Positive 63 INCB# [003] 63 Anaplastic 63 homozygous FH 63 diabetic nephropathy 63 cell lymphoma ALCL 63 IV metastatic melanoma 63 hepatocellular cancer 63 polyneuropathy CIDP 63 generalized seizures 63 VAPRISOL 63 papillary renal cell carcinoma 63 cell acute lymphoblastic 63 Xanafide 63 medullary thyroid cancer 63 epithelial tumors 63 relapsing remitting MS RRMS 63 dirucotide 63 idarubicin 63 dasatinib Sprycel 63 Dacogen decitabine 63 myelofibrosis MF 63 vWD 63 azacitidine 63 chronic myeloid leukemia CML 63 relapsed multiple myeloma 63 pediatric malignancies 63 Hurthle cell 63 follicular lymphoma 63 Chronic Lymphocytic Leukemia CLL 63 imatinib resistant 63 PAOD 63 fungoides 63 Non Hodgkin 63 hepatorenal syndrome 63 Chronic Myeloid Leukemia 63 neuroendocrine tumors 63 metastatic gastric 63 proliferator activated receptor 63 Wegener granulomatosis 63 relapsed Acute Myeloid 63 non squamous NSCLC 63 Pemetrexed 63 Soft Tissue Sarcoma 63 Acute myeloid leukemia 63 superficial bladder cancer 63 hematologic malignancies 63 Metastatic 63 tumor lysis syndrome 63 neuroendocrine carcinoma 63 PNP inhibitor 63 chronic myeloid 63 antibody MAb 63 metastatic kidney 63 proliferative diabetic retinopathy 63 relapsing remitting multiple sclerosis 62 carcinoid tumors 62 parathyroid carcinoma 62 NYHA Class II 62 Non Hodgkin lymphoma 62 astrocytoma 62 hematologic toxicity 62 carcinoid 62 nasopharyngeal carcinoma 62 Renal Cell Carcinoma RCC 62 Cell Lymphoma 62 systemic lupus erythematosus SLE 62 Diffuse Large B 62 idiopathic thrombocytopenic purpura 62 cervical intraepithelial neoplasia 62 Squamous 62 familial hypercholesterolemia FH 62 SHPT 62 unfavorable cytogenetics 62 Acute myeloid leukemia AML 62 aplastic anemia AA 62 chronic GVHD 62 Idiopathic pulmonary fibrosis 62 Chronic Lymphocytic Leukemia 62 SUTENT 62 hepatocellular carcinoma HCC 62 hepatocellular carcinoma 62 malignant neoplasm 62 Acute lymphoblastic leukemia 62 Nilotinib 62 gastrointestinal stromal tumors GIST 62 standard chemotherapy regimens 62 Bronchiectasis 62 advanced hepatocellular carcinoma 62 nonalcoholic steatohepatitis NASH 62 Velcade bortezomib 62 GISTs 62 intravesical therapy 62 gemcitabine Gemzar ® 62 peritumoral brain edema 62 subependymal giant cell 62 anaplastic astrocytoma 62 efalizumab 62 sorafenib Nexavar 62 histone deacetylase HDAC inhibitor 62 anemias 62 herpes zoster shingles 62 metastatic GIST 62 Severe Primary IGFD 62 Azacitidine 62 Certolizumab pegol 62 Irinotecan 62 astrocytomas 62 malignant fibrous histiocytoma 62 Ribavirin causes 62 dasatinib 62 polycythemia vera essential thrombocythemia 62 geographic atrophy 62 systemic anaplastic large 62 Fludara ® 62 Letairis ambrisentan 62 phase IIb trial 62 AA Amyloidosis 62 recurrent colorectal cancer 62 antimetabolite 62 Nexavar sorafenib 62 leukoencephalopathy 62 erythematosus 62 TORISEL 62 acute myeloid leukemia 62 romiplostim 62 idiopathic pulmonary fibrosis IPF 62 invasive aspergillosis 62 hepatic metastases 62 hemolytic anemia 62 mTOR inhibitor 62 adverse cytogenetics 62 carcinoid syndrome 62 juvenile myelomonocytic leukemia 62 grade dysplasia 62 familial adenomatous polyposis 62 T2DM 62 CHOP chemotherapy 62 Enzyme Replacement Therapy 62 visilizumab 62 TACI Ig 62 candidemia 62 Leber Hereditary Optic Neuropathy 62 metastatic RCC 62 systemic fungal infections 62 Mitoxantrone 62 PEGylated interferon beta 1a 62 glioblastoma multiforme GBM 62 breast carcinomas 62 metastatic colon cancer 62 neoplasias 62 autoantibody positive 62 histologically confirmed 62 polycythemia vera PV 62 heparin induced thrombocytopenia 62 immunomodulatory therapy 62 tyrosine kinase inhibitors TKIs 62 progressive neurodegenerative disorder 62 myeloproliferative disorders 62 infantile onset 62 metastatic colorectal 62 Relapsing Remitting Multiple Sclerosis 62 pediatric acute lymphoblastic 61 haematological malignancies 61 biliary tract cancer 61 Bevacizumab 61 MELAS 61 endothelin receptor antagonists 61 hepatic cirrhosis 61 lumiliximab 61 relapsed leukemia 61 severe neutropenia 61 demethylation agents 61 Acute Myeloid Leukaemia 61 nilotinib 61 NAGS deficiency 61 bronchogenic carcinoma 61 cisplatin chemotherapy 61 hypersensitivity reaction 61 Aortic stenosis 61 imatinib Gleevec 61 completely resected 61 remission induction 61 Relapsed Refractory 61 Torisel 61 Telintra 61 Advanced Renal Cell 61 refractory NSCLC 61 Leukemias 61 Glioblastoma multiforme GBM 61 refractory cutaneous T 61 eosinophilic asthma 61 lactic acidosis 61 fallopian tube carcinoma 61 myeloproliferative disorder 61 Systemic lupus erythematosus 61 cervical carcinoma 61 osteosarcoma Ewing sarcoma 61 AGILECT R 61 myeloid 61 cytotoxic chemotherapy 61 NMIBC 61 Acute Myeloid Leukaemia AML 61 Systemic Lupus Erythematosus SLE 61 invasive fungal infections 61 T#I mutation 61 neurological manifestations 61 Hashimoto thyroiditis 61 deletion 5q 61 essential thrombocythemia ET 61 unknown etiology 61 multiple myeloma MM 61 gastrointestinal stromal tumors GISTs 61 metastatic lung cancer 61 LymphoStat B belimumab 61 gastrointestinal stromal tumor GIST 61 PEGINTRON TM 61 pulmonary hypertension PH 61 FluCAM arm 61 BARACLUDE ® 61 Gleevec imatinib mesylate 61 HeFH 61 situ CIS 61 heavily pretreated 61 diffuse gastric 61 IV melanoma 61 follicular NHL 61 taxane chemotherapy 61 systemic amyloidosis 61 tuberous sclerosis TS 61 psoriatic arthritis PsA 61 Kit CD# positive 61 multiple myeloma 61 PNET 61 pancreatic adenocarcinoma 61 lysosomal storage disease 61 thyrotoxicosis 61 Mantle Cell Lymphoma 61 MGUS 61 rFVIIa 61 Gleevec imatinib 61 juvenile idiopathic arthritis JIA 61 proliferative retinopathy 61 relapsed acute myelogenous 61 Eculizumab 61 TELINTRA 61 HNSCC 61 relapsing remitting MS 61 recurrent glioblastoma multiforme GBM 61 Ceflatonin 61 primary hyperparathyroidism 61 cancer mCRC 61 JMML 61 dirucotide MBP# 61 pulmonary arterial hypertension 61 xanthine oxidase inhibitor 61 paragangliomas 61 Pulmonary hypertension 61 stage IIIb IV 61 fibromyalgia syndrome 61 Brentuximab Vedotin SGN 61 targeted radiotherapeutic 61 EGFR inhibitors 61 sJIA 61 Atypical Hemolytic Uremic Syndrome 61 histologic subtype 61 malignant lymphoma 61 nephropathic cystinosis 61 severe hypercholesterolemia 61 herpetic keratitis 61 Alzheimer Disease AD 61 Adenocarcinoma 61 refractory indolent non 61 five MDS subtypes 61 alvespimycin 61 vinca alkaloid 61 YONDELIS 61 PEG IFN 61 diagnosed Ph + 61 Lymphocytic 61 transthyretin amyloidosis 61 severe renal impairment 61 terlipressin 61 sunitinib malate 61 biologic therapy 61 galiximab 61 Chronic myeloid leukemia 61 elacytarabine 61 curative resection 61 imatinib Gleevec ® 61 inhibitor RG# 61 paroxysmal nocturnal hemoglobinuria 61 monoclonal antibody conjugated 61 interstitial pneumonitis 61 temsirolimus 61 MDS AML 60 MPGN 60 nonsense mutation 60 histologies 60 HSCT 60 Enzastaurin 60 sorafenib tablets 60 severe malignant osteopetrosis 60 pancytopenia 60 small lymphocytic lymphoma 60 Lupus nephritis 60 prostate adenocarcinoma 60 docetaxel Taxotere ® 60 Li Fraumeni Syndrome 60 Sorafenib 60 malignant ascites 60 myeloproliferative 60 Glioblastoma Multiforme GBM 60 pleural mesothelioma 60 metastatic NSCLC 60 Annamycin 60 Critical Limb Ischemia CLI 60 investigational monoclonal antibody 60 lomitapide 60 hormone refractory prostate cancer 60 Venous thromboembolism 60 polycythemia vera 60 MKC# MT 60 paroxysmal nocturnal hemoglobinuria PNH 60 vandetanib 60 hyperphenylalaninemia HPA due 60 systemic ALCL 60 resectable 60 cervical dysplasia 60 refractory CTCL 60 chronic granulomatous disease 60 Psoriatic arthritis 60 alkylating agents 60 T#I [002] 60 dexamethasone Decadron 60 Peginterferon alfa 2b 60 pemphigus vulgaris 60 T1c 60 bendamustine 60 imatinib mesylate 60 juvenile idiopathic arthritis 60 glomerulonephritis 60 ribavirin therapy 60 HIV HCV coinfected 60 Ceflatonin R 60 SPRYCEL ® 60 Voreloxin 60 onset diabetes mellitus 60 Moyamoya disease 60 hemophagocytic lymphohistiocytosis 60 LHRH antagonists 60 colorectal liver metastases 60 idiopathic myelofibrosis 60 fatal neurodegenerative 60 Myelodysplastic syndromes MDS 60 TTF Therapy 60 tyrosine kinase inhibitors 60 Vandetanib 60 refractory AML 60 Ozarelix 60 T1DM 60 relapsing multiple sclerosis 60 Idiopathic Pulmonary Fibrosis 60 anthracycline taxane 60 metastatic pancreatic 60 chronic idiopathic thrombocytopenic purpura 60 measurable tumor regressions 60 intraepithelial neoplasia 60 Naive Patients 60 colorectal cancer CRC 60 B Cell Lymphoma 60 leukemia CML 60 osteosarcomas 60 Alocrest 60 Non Alcoholic Steatohepatitis 60 neoplasm 60 Dasatinib 60 squamous cell carcinoma SCC 60 levodopa therapy 60 overt nephropathy 60 lobular carcinoma 60 Papillary 60 proctitis 60 Lenalidomide 60 hepatic encephalopathy 60 dual PPAR peroxisome 60 precancerous cervical lesions 60 leukaemias 60 von Willebrand disease 60 Aflibercept 60 non squamous 60 Dapagliflozin 60 MGd 60 chronic immune thrombocytopenic 60 BRAF inhibitor 60 International Prognostic Scoring 60 Ambrisentan 60 HER2 overexpression 60 docetaxel Taxotere R 60 histological subtype 60 febrile neutropenia 60 peripheral sensory neuropathy 60 infliximab Remicade 60 ATTR 60 Relapsing remitting MS 60 leiomyosarcoma 60 refractory acute promyelocytic 60 transplantation HCT 60 chronic thromboembolic pulmonary 60 dose melphalan 60 Gorlin syndrome 60 azacytidine 60 seminoma 60 lenalidomide Revlimid R 60 idiopathic PAH 60 CTEPH 60 ductal breast cancer 60 GvHD 60 MYCN amplification 60 Erlotinib 60 Eisenmenger syndrome 60 Lung transplantation 60 Pulmonary arterial hypertension 60 systolic hypertension 60 Crizotinib 60 bevacizumab Avastin ® 60 Cholangiocarcinoma 60 prostate cancer CaP 60 refractory Hodgkin lymphoma 60 tanespimycin 60 Chronic Myelogenous Leukemia 60 transplantation HSCT 60 assessing T DM1 60 BRAF gene 60 Cyclophosphamide 60 corticosteroid therapy 60 Sjögren syndrome 60 BR.# 60 pancreatic neuroendocrine tumors 60 renal dysfunction 60 CLL SLL 60 nonalcoholic steatohepatitis 60 trabectedin 60 chemotherapy cisplatin 60 anterior uveitis 60 adenomatous polyps 60 previously untreated follicular 60 methimazole 60 hyperkalemia 60 BAY #-# 60 gastric carcinoma 60 Eltrombopag 60 dacarbazine DTIC 60 proteasome inhibitor 60 Parkinsonian Syndromes 60 advanced unresectable 60 heavily pretreated patients 60 TNF Tumor Necrosis Factor 60 thymic carcinoma 60 acute promyelocytic leukemia 60 cIAI 60 adalimumab Humira 60 bone metastasis 60 hepatic encephalopathy HE 60 metastatic hormone refractory 60 metastatic colorectal carcinoma 60 Vicinium TM 59 Vaprisol 59 K ras mutations 59 nonmetastatic 59 orally administered inhibitor 59 Adenomas 59 total thyroidectomy 59 hepatitis C HCV 59 allogeneic stem cell 59 FOLOTYN ® 59 cytogenetic responses 59 Adjuvant chemotherapy 59 systemic juvenile idiopathic 59 Basal cell 59 rheumatoid arthritis psoriatic arthritis 59 DMARD therapy 59 Bortezomib 59 hypophosphatemia 59 Glioblastoma multiforme 59 malignant neoplasms 59 Multiple Myeloma MM 59 stage IIIA 59 LHON 59 Decitabine 59 common hematologic malignancy 59 primary hypercholesterolemia 59 vinorelbine 59 AVASTIN 59 bladder cancers 59 NSCLC 59 ribavirin RBV 59 phenylketonuria 59 MDS MPD 59 diffuse intrinsic pontine glioma 59 autologous transplants 59 esophagitis 59 CIN3 59 del 5q 59 Troxatyl 59 Rituximab 59 neoplasia 59 colorectal adenoma 59 Leukine ® 59 CTAP# Capsules 59 chlorambucil 59 cutaneous squamous cell carcinoma 59 untreated de novo 59 AGHD 59 rALLy 59 ZACTIMA 59 Navelbine ® 59 hyperparathyroidism 59 Pseudomonas aeruginosa infections 59 non hodgkin lymphoma 59 oral Hycamtin 59 Genentech Rituxan 59 torsade de pointes 59 choroidal neovascularization 59 riociguat 59 metastatic pancreatic cancer 59 diabetes mellitus T2DM 59 Hurler syndrome 59 symptomatic BPH 59 prostate carcinoma 59 hypophosphatasia 59 severe oral mucositis 59 refractory multiple myeloma 59 Ibritumomab Tiuxetan 59 endometrial hyperplasia 59 lymphomas 59 paraganglioma 59 partial remissions 59 serous ovarian cancer 59 Tumor Necrosis Factor 59 pyelonephritis 59 Perifosine 59 DOXIL 59 Natalizumab 59 Medullary thyroid cancer 59 elotuzumab 59 LHRH agonists 59 Infusion Reactions Severe 59 Hepatocellular Carcinoma 59 Glioblastoma 59 keloid scarring 59 CIN2 + 59 prolonged QT interval 59 Systemic lupus erythematosus SLE 59 hypoparathyroidism 59 Leber Congenital Amaurosis LCA 59 neutropaenia 59 corticosteroid dexamethasone 59 cetuximab Erbitux R 59 nucleoside analog 59 multiforme 59 Metastatic Colorectal Cancer 59 alefacept 59 Cloretazine ® 59 hypercholesterolaemia 59 bevacizumab Avastin 59 alpha1 antitrypsin AAT deficiency 59 Rituxan rituximab 59 CTCL 59 cetuximab Erbitux ® 59 urothelial bladder cancer 59 MPS VI 59 Host Disease GvHD 59 dysplastic lesions 59 Hereditary angioedema HAE 59 carcinoma HCC 59 Surgical resection 59 adriamycin 59 GW# [003] 59 pancreatic insufficiency 59 lymphoma subtypes 59 hyperammonemia 59 thrombocytopenic patients 59 Vidaza azacitidine 59 metastatic CRC 59 blastic phase 59 Diabetic Nephropathy 59 adrenal insufficiency 59 malignancies 59 Carcinoid tumors 59 cytogenetic abnormalities 59 relapsed ovarian cancer 59 erythematosus SLE 59 alpha interferons 59 sarcomatoid 59 Clevudine 59 cystic fibrosis CF 59 renal insufficiency 59 CRVO 59 Dacogen injection 59 pT2 59 Mipomersen 59 Campath alemtuzumab 59 SNT MC# 59 induce orthostatic hypotension 59 mixed hyperlipidemia 59 lymphoproliferative disorder 59 luteinizing hormone releasing 59 biologic DMARD 59 pediatric Crohn disease 59 diabetic gastroparesis 59 Safinamide 59 MYLOTARG 59 basal cell nevus syndrome 59 Crohn disease CD 59 ankylosing spondylitis AS 59 Major Depressive Disorder MDD 59 Myelodysplastic syndrome 59 AAT Deficiency 59 ovarian carcinoma 59 disease CDAD 59 alfa 2a 59 neoplasia PIN 59 methotrexate therapy 59 MPS IVA 59 Idiopathic Thrombocytopenic Purpura ITP 59 hormone LHRH antagonist 59 post transplant lymphoproliferative 59 Phase #b/#a clinical 59 adenocarcinomas 59 chronic lymphocytic leukemia 59 Retreatment 59 Myelodysplastic syndromes 59 hypomethylating agents 59 MCyR 59 relapsed SCLC 59 ADHF 59 fludarabine 59 sarcomas 59 neutropenia dehydration dyspnea 59 1 diabetes T1D 59 Burkitt lymphoma 59 allogeneic bone marrow 59 kidney urologic 59 Cleviprex TM clevidipine 59 Multiple myeloma 59 Pixantrone 59 underwent resection 59 Hypotension 59 indolent lymphoma 59 arthritis PsA 59 Merck KGaA Erbitux 59 hematological malignancies 59 hypercholesterolemia 59 cytotoxic therapy 59 alveolar rhabdomyosarcoma 59 Friedreich ataxia 59 Tyrosine Kinase Inhibitors 59 CIMZIA ™ 59 Kepivance 59 decitabine 59 AAT deficiency 59 trans retinoic acid ATRA 59 BENICAR HCT 59 mCRC 59 metastatic renal 59 Pharmacokinetics PK 59 forodesine 59 calcineurin inhibitors 59 trans retinoic acid 59 lymphoblastic lymphoma 59 follicular thyroid cancer 59 Mitomycin C 59 dose cytarabine 59 angiosarcoma 59 chronic myocardial ischemia 59 VNP#M 59 epithelial ovarian cancer 59 Onco TCS 59 castration resistant prostate cancer 59 hyperoxaluria 59 recurrent GBM 59 Myelodysplastic Syndromes MDS 59 bortezomib Velcade 59 DLBCL 59 non Hodgkin lymphomas 59 Pivotal Phase III 59 systemic autoimmune 59 myocardial infarction ventricular fibrillation 59 hemorrhagic cystitis 59 mycophenolate mofetil MMF 59 hormone refractory metastatic prostate 59 renal cell carcinomas 59 pheochromocytomas 59 anaplastic thyroid cancer 59 Tamibarotene 59 inherited neurodegenerative disorder 59 cytoreduction 59 lintuzumab SGN 59 sorafenib Nexavar ® 58 Doxil ® 58 radiation sensitizer 58 Neutropenia 58 tigecycline 58 cell carcinoma 58 MKC# MKC# PP 58 Temsirolimus 58 IBS C 58 malignant pleural mesothelioma MPM 58 gastric adenocarcinoma 58 untreated AML 58 pseudobulbar affect PBA 58 acute myelogenous leukemia 58 Hematologic 58 TKI therapy 58 cerebral vasospasm 58 operable breast cancer 58 erythropoietic 58 Friedreich Ataxia FRDA 58 CsA 58 hormone refractory 58 MYCAMINE 58 intestinal metaplasia 58 anemia neutropenia 58 Sjogren Syndrome 58 Neovascular AMD 58 aortic dissections 58 Thrombocytopenia 58 acute humoral rejection 58 treats paroxysmal nocturnal 58 Syndrome LEMS 58 concomitant medications 58 systemic mastocytosis 58 posaconazole 58 HoFH 58 FOLFOX6 58 hematopoietic cancers 58 PTLD 58 Tasigna nilotinib 58 anaplastic astrocytomas 58 immunodeficiencies 58 recurrent ovarian cancer 58 superficial basal cell carcinoma 58 fatal neurodegenerative disorder 58 Diabetic nephropathy 58 heterozygous FH 58 Noxafil 58 clonic seizures 58 autologous SCT 58 follicular lymphomas 58 Gliomas 58 MabCampath 58 IL# PE#QQR 58 unresectable stage 58 Malignancies 58 candidiasis 58 Radioimmunotherapy 58 stable angina pectoris 58 prostate pancreatic 58 Folfox 58 gouty arthritis 58 Morquio 58 generalized tonic clonic seizures 58 de novo AML 58 acyclovir Lauriad R 58 serologically active systemic lupus 58 depsipeptide 58 dysglycemia 58 squamous 58 lymphoid malignancies 58 transthyretin TTR mediated amyloidosis 58 Complicated Skin 58 skeletal metastases 58 immune thrombocytopenic purpura ITP 58 metastatic carcinoid tumors 58 progressive dyspnea 58 myelosuppression 58 Fludara 58 sorafenib 58 echinocandin 58 mildly symptomatic 58 generation purine nucleoside 58 Acute Coronary Syndromes ACS 58 nonmelanoma skin cancers 58 ocular disorders 58 EOquin 58 Peripheral neuropathy 58 FLT3 58 pulmonary metastases 58 metastatic uveal melanoma 58 HER2 positive breast cancer 58 alkylating agent 58 refractory gout 58 immunological diseases 58 urothelial carcinoma 58 Malignant Melanoma 58 metastatic castration resistant 58 cancer cachexia 58 Trastuzumab 58 ALT flares 58 mycophenolate mofetil 58 CIMZIA TM 58 severe hepatomegaly 58 micafungin 58 RRMS patients 58 tyrosine kinase inhibitor 58 somatostatin analogue 58 unstable angina UA 58 erlotinib Tarceva 58 node metastases 58 cytopenia 58 interferon therapy 58 squamous cell lung cancer 58 Pegylated Liposomal Doxorubicin 58 cranial radiation 58 Peripheral Artery Disease 58 RAS mutations 58 hepatic impairment 58 fulminant 58 TMS Therapy 58 Neovascular Age Related Macular 58 diabetes mellitus DM 58 RNAi therapeutic targeting 58 cediranib 58 cetuximab Erbitux 58 lymphoblastic leukemia 58 EXJADE 58 LHRH receptor positive 58 hepatic failure 58 Azedra 58 non Hodgkin Lymphoma 58 infusional 5-FU/LV 58 gemcitabine Gemzar 58 reslizumab 58 cystic fibrosis chronic pancreatitis 58 serum phosphate 58 ribavirin Copegus ® 58 solid tumors 58 dacarbazine 58 thrombocytosis 58 vinca alkaloids 58 ASCT 58 dopaminergic therapy 58 Pegasys ® 58 Stomatitis 58 elevated triglyceride levels 58 Fibrillex TM 58 Sutent sunitinib 58 Endometrial cancer 58 hyperphosphatemia